Firms
Theme

WRB

W.R. Berkley Corporation · NYSE

News

17 latest

Zacks Investment Research

UVE Q3 Earnings Beat Estimates on Lower Losses & Premium Growth

Universal Insurance Holdings (UVE) reported Q3 2026 adjusted earnings of $1.93 per share, beating consensus by 44%, with revenues of $0.43 billion surpassing estimates by 13.2%. The company achieved a net combined ratio of 91% (improved 540 basis points), driven by stronger underwriting results and premium growth outside Florida.

Zacks Investment Research

W.R. Berkley (WRB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

W.R. Berkley reported Q3 2026 revenue of $3.76 billion, up 1.8% year-over-year, slightly missing the $3.8 billion consensus estimate. EPS of $1.17 exceeded expectations of $1.14.

Zacks Investment Research

W.R. Berkley (WRB) Tops Q3 Earnings Estimates

W.R. Berkley reported Q3 2026 earnings of $1.17 per share, beating consensus estimates of $1.14, but missed revenue expectations with $3.76 billion versus the estimated $3.84 billion. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The property and casualty insurance industry ranks in the top 26% of Zacks industries.

Zacks Investment Research

Is a Beat in the Cards for W.R. Berkley This Earnings Season?

W.R. Berkley Corporation is predicted to beat third-quarter 2026 earnings expectations with a +1.31% Earnings ESP and Zacks Rank #3. Insurance premiums are expected to grow 3.6% while reinsurance premiums may decline 0.9%. The combined ratio is estimated at 92.77%, supported by disciplined underwriting but pressured by elevated catastrophe losses from severe convective storms.

Zacks Investment Research

Earnings Preview: Chubb (CB) Q3 Earnings Expected to Decline

Chubb is expected to report a year-over-year earnings decline despite revenue growth for Q3 2026, with an Earnings ESP of -0.10% and Zacks Rank #3 making an earnings beat unlikely. Meanwhile, W.R. Berkley shows stronger prospects with a positive Earnings ESP of +1.31% and Zacks Rank #3, suggesting it is more likely to beat consensus estimates.

Zacks Investment Research

W.R. Berkley (WRB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

W.R. Berkley is expected to report Q3 2026 earnings on October 19 with a year-over-year EPS increase of 3.6% to $1.14 per share and revenue growth of 3.1% to $3.8 billion. The company has a positive Earnings ESP of +1.31% combined with a Zacks Rank #3, suggesting a likely earnings beat. The company has beaten consensus estimates in 3 of the last 4 quarters, including a +16.51% surprise in the most recent quarter.

Zacks Investment Research

Here's Why W.R. Berkley (WRB) is a Strong Momentum Stock

W.R. Berkley (WRB), a Fortune 500 insurance company, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a B VGM Score. The stock has shown strong momentum with a Momentum Style Score of A and shares up 2.9% over the past four weeks. Six analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $4.90 per share and an average earnings surprise of +8.4%.

Zacks Investment Research

AFG's Specialty Focus to Drive Above-Market Premium Growth

American Financial Group (AFG) achieved 6% specialty P&C premium growth in Q2 2026, outpacing the broader market. The company is shifting from pricing-driven growth to new business, exposure growth, and market-share gains.

Mentions WRB

Zacks Investment Research

KNSL Q3 Earnings Beat Estimates on Strong Investment Income

Kinsale Capital Group (KNSL) reported Q3 2026 operating earnings of $5.70 per share, beating estimates by 15.15% with a 9.4% year-over-year increase. However, total revenues declined 8.6% to $454.8 million, missing consensus.

Zacks Investment Research

Globe Life Q3 Earnings Miss Estimates on Weak Underwriting Income

Globe Life reported Q3 2026 operating EPS of $4.84, slightly missing estimates but growing 0.6% year-over-year. Premium revenues rose 6.5%, but underwriting income fell 4.2% and expenses surged 11.5%, pressuring profitability.

The Motley Fool

W. R. Berkley: 3 Key Takeaways for Long-Term Investors

W. R. Berkley reported record Q3 2026 underwriting profit of $296 million with double-digit investment portfolio growth. The company achieved 20% operational efficiency gains through AI and data automation in policy processing, benefited from higher fixed income yields on its $24 billion portfolio, and maintained underwriting discipline by reducing reinsurance exposure in soft markets.

Zacks Investment Research

TRV Q3 Earnings Beat on Reserve Gains and Investment Income

The Travelers Companies (TRV) reported Q3 2026 core earnings of $9.18 per share, beating estimates by 29.8%, with revenues of $12.45 billion. The company achieved a combined ratio of 86.8% and record net investment income of $1.1 billion, though catastrophe losses reached $538 million. TRV returned $1.77 billion to shareholders and maintains strong capital position with $29 billion in equity.

Zacks Investment Research

Progressive's Q3 Earnings Top Estimates on Higher Premiums

Progressive Corporation reported Q3 2026 earnings per share of $4.60, beating consensus estimates by 3.1% with a 13.6% year-over-year increase. Net premiums written grew 4% to $22.3 billion, and the combined ratio improved 80 basis points to 88.7.

Zacks Investment Research

Can Travelers Retain Its Surprise Streak This Earnings Season?

The Travelers Companies (TRV) is expected to report a 15.2% decline in Q3 2026 EPS to $6.90 with flat revenues at $12.4B. Despite the projected decline, the stock has a positive Earnings ESP of +0.77% and Zacks Rank #3, suggesting a potential earnings beat driven by higher investment income and better pricing. However, catastrophe claims could offset gains from strong retention and underwriting discipline.

Zacks Investment Research

CB Stock Rises 22% in a Year: What Should Investors Know?

Chubb Limited shares have gained 22% over the past year, outperforming the insurance industry average of 3.1%, driven by strong earnings growth, disciplined underwriting, and effective capital management. The company maintains a strong ROE of 14.5% and is expected to grow 2026 EPS by 11.7% year-over-year. However, the stock trades at a premium valuation and faces risks from catastrophe losses and softening commercial insurance pricing.

Zacks Investment Research

Markel Group Can Offset Softer Pricing With Underwriting Discipline

Markel Group (MKL) reported improved Q2 2026 results with a combined ratio of 93% and underwriting income more than doubling to $142.1 million. However, the company faces challenges from softening insurance pricing and catastrophe-related volatility. While operational discipline and portfolio optimization support sustainability, the stock trades at a discount to peers and has underperformed the industry over the past year.

Zacks Investment Research

American Financial Outperforms Industry in a Year: Time to Hold?

American Financial Group (AFG) has outperformed its industry peers with a 1.8% year-to-date gain, driven by 6% net premium growth in its Specialty P&C business, record investment income, and a strong 20.3% trailing 12-month ROE. The company maintains a solid capital position of $6.81 billion and has raised its dividend for the 21st consecutive year, with analysts projecting 19.4% EPS growth for 2026.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $WRB · 0 threads

Sign in to post on $WRB

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev